Clinical Trial Update: A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

This Phase 1 trial, sponsored by Novo Nordisk, investigates the impact of nocturnal hypoglycemia on sleep in adults with Type 2 diabetes; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED